GlobeNewswire Inc.··NaStryker Schedules 2026 Annual Meeting, Raises Quarterly Dividend to $0.88
Stryker schedules virtual annual shareholder meeting for May 6, 2026, declares $0.88 quarterly dividend payable April 30, 2026.
SYKdividendshareholders
S
$SYK
7 articles found4 positive
1 negative
2 neutral
GlobeNewswire Inc.··NaGlobeNewswire Inc.··Mordor IntelligenceOrthobiologics Market Set to Hit $9.5B by 2031 as Regenerative Medicine Surges
Global orthobiologics market projected to grow 43% to $9.52B by 2031, driven by rising osteoarthritis and regenerative therapy advancements.
JNJSYKMDTZBHBVS+1regenerative medicinestem cell therapy
Benzinga··Vandana SinghStryker Hit by Iran-Linked Cyber Attack; Stock Falls 3.82% Amid Device Wipeout
Stryker hit by suspected Iran-linked cyberattack wiping devices globally; stock falls 3.82% as company investigates with Microsoft.
MSFTSYKgeopolitical tensionsdata breach
GlobeNewswire Inc.··Verified Market Research®Medical Device Cleaning Market to Nearly Double by 2032 on Infection Control Focus
Medical device cleaning market projected to nearly double to $3.74B by 2032, driven by stricter infection control regulations and shift toward reusable devices in healthcare.
JNJMMMECLSYKMDT+2medical device cleaninginfection control
GlobeNewswire Inc.··Sns InsiderRigid Endoscopes Market Poised to Reach $11.52B by 2033 on Minimally Invasive Demand
Rigid endoscopes market to grow from $7.36B to $11.52B by 2033, driven by minimally invasive surgery demand and technological advances in imaging capabilities.
SYKMDTBSXmedical devicesambulatory surgery centers
GlobeNewswire Inc.··Sns Insider ResearchFibrin Sealant Market Poised to Double to $3.57B by 2035 Amid Surgical Demand
Fibrin sealant market to double from $1.60B to $3.57B by 2035, driven by surgical demand and minimally invasive techniques despite accessibility challenges in developing regions.
JNJPFESYKMDTBAX+1market growthminimally invasive surgery
GlobeNewswire Inc.··Sns Insider ResearchUterine Fibroid Treatment Market Poised for 7.63% Annual Growth Through 2033
Global uterine fibroid treatment market projected to grow 7.63% annually through 2033, reaching $9.43 billion. Growth driven by high disease prevalence and minimally invasive surgical advances.
JNJPFEABBVSYKMDT+9market growthminimally invasive procedures